Frontiers in Peritoneal Dialysis

ISBN-13: 9783662117866 / Angielski / Miękka / 2013 / 662 str.

John F. Maher; James F. Winchester

Opis

III. International Symposium on Peritoneal Dialysis

Spis treści

Morphology, Physiology, Kinetics, Drugs.- The Ultrastructure of the Parietal Peritoneum in Normal and Uremic Man and in Patients on CAPD.- The Morphology of the Peritoneum in CAPD Patients.- Fenestrated Capillaries in the Human Parietal Peritoneum and Rabbit Diaphragmatic Peritoneum.- Lymph Flow from the Peritoneal Cavity in CAPD Patients.- A Distributed Model of Peritoneal Transport.- Maximal Peritoneal Pore Size Determined by Dextran Transport.- Peritoneal Absorption of Macromolecules.- Peritoneal Membrane Permeability for High and Low Molecular Weight Proteins (H/LMWP) in CAPD.- Follow-up of Peritoneal Mass Transfer Properties in Long-term CAPD Patients.- Dependence of Middle Molecular Clearance on Protein Concentration of Peritoneal Fluid.- An International Survey of Ultrafiltration in CAPD.- Changes in Ultrafiltration and Solute Transport During CAPD.- Prediction of Changes in Transperitoneal Water Transport During CAPD—A Prospective Study.- Influence of Blood Flow and Plasma Proteins on UF Rate in Peritoneal Dialysis.- Prognostic Value of Peritoneal Equilibration Curves in CAPD Patients.- Role of Peritoneal Membrane Hydration in UF Capacity of Patients on CAPD.- Studies on Peritoneal UF Loss: The UF Coefficient (K) as an Index of the PM Filtration Efficiency.- Increased Peritoneal Ultrafiltration Due to Amphotericin B Augmented Sodium Transport.- Serum Concentration and Peritoneal Transfer of Aluminum during Treatment by CAPD.- Calcium Peritoneal Mass Transfer in CAPD.- Changes in Plasma Protein Spectra after IP Injection of Hypertonic and Isotonic Solutions.- Pharmacokinetics of Cefotaxime during CAPD.- Multiple Dose IP Vancomycin Kinetics during CAPD.- IP Administration of Moxalactam during CAPD.- Technology Access, Solutions.- Experimental and Clinical Origins of Peritoneal Dialysis for Renal Failure.- The Sorbent Suspension Reciprocating Dialyzer for Use in Peritoneal Dialysis.- Application of Antibiotic Bonding to CAPD Catheters.- Clinical Experience in CAPD Using Flame-Lock Connecting Device: A Group Study.- Intraluminal Thermosterilization Using a Microwave Autoclave.- The Ultraviolet Germicidal System: The Elimination of Distal Contamination in CAPD.- Biofilm on Tenckhoff Catheters: A Possible Source for Peritonitis.- CAPD: One Cuff vs Two Cuff Catheters in Reference to Incidence of Infection.- Profound Reduction in Peritonitis in CAPD Using Travenol System IIR Connectors and Betadine.- CAPD Peritonitis and Different Connecting Devices: A Statistical Comparison.- Clinical Application of a Miniaturized Variant of the Perugia CAPD Connection System.- Peritonitis Prevention in CAPD: Efficacy of a Y-Connector and Disinfectant.- Long-Term Use of Unidirectional Bacteriologic Filters to Reduce Peritonitis Frequency in CAPD.- Skin Reaction Against the Catheter: An Explanation for Exit Site Infection in CAPD.- Elimination of Tunnel Infection.- Successful Peritoneal Catheter Placement after Major Abdominal Surgery or Peritonitis.- Reduction of Complications with Bedside Lateral Placement of Catheter for CAPD.- Microcomputer Peritoneal Programmer in Service of Acute Peritoneal Dialysis.- A Comparison of Glucose Polymer and Dextrose as Osmotic Agents in CAPD.- Glucose Polymer As an Osmotic Agent in CAPD.- Sustained UF with Gelatin Dialysis Solution during Long Dwell Dialysis Exchanges in Rats.- Glycerol Instead of Dextrose As an Osmotic Agent in CAPD.- Potentially Irritant Glucose Metabolites in Unused CAPD Fluid.- CAPD Using a High Calcium Concentration.- Is Peritoneal Ultrafiltration Influenced by Acetate or Lactate Buffers?.- Evolution of Ultrafiltration in CAPD According to the Dialysis Fluid Buffer.- Comparison of Different Volume Markers in Peritoneal Dialysis.- Critical Evaluation of the Injection Site for Insulin in CAPD for Diabetic Patients.- Clinical Experiences.- Overview of Three Year Experience of the National CAPD Registry of the National Institutes of Health.- Multi-center Study on the Outcome of Patients on CAPD and Hemodialysis.- CAPD in Italy: A Multicenter Study.- Is CAPD a Second Class Treatment?.- CAPD and Protein-Permeating Hemodialysis: A Clinical Comparison.- CAPD in the Elderly—Regional Experience.- Italian Multicentric Study on Diabetic Uremic Patients Treated by CAPD.- CAPD in the Diabetic; Comparison with Nondiabetics on CAPD.- CAPD in Infants.- Outcome of High Risk Patients on CAPD.- Four Year Experience in CAPD.- Prognostic Correlates in Ambulatory Peritoneal Dialysis Versus Hemodialysis.- Peritoneal Dialysis for In-Hospital Patients.- Renal Transplantation in Patients on CAPD.- Hemodialysis Requirements of CAPD Patients.- Home CAPD Nurse—An Asset to a CAPD Program.- The Telephone—An Underestimated Resource for CAPD Nursing Management.- Psychological and Economic Assessment of Peritoneal Dialysis Patients in Nigeria.- CAPD on Alternate Days.- Low BUN: A Negative Prognostic Indicator Early in CAPD.- Two Years Experience with High Volume Low Frequency CAPD.- Successful Use of CAPD in Refractory Heart Failure.- Nutritional, Metabolic, and Physiological Effects.- Nutritional Requirements with CAPD.- Muscle Free Amino Acids in Patients Treated with CAPD.- Total Body Potassium and Fat Free Mass in CAPD.- Effect of Increased Insulin Secretion during CAPD on Potassium Metabolism.- Amino Acid Versus Glucose Dialysis in Children on CAPD.- Nutritional Aspects in Children on CAPD.- Intraperitoneal Versus Oral Glucose Load in CAPD Patients.- The Effect of CAPD on Lipid Abnormalities Detected by Apoproteins and Ultracentrifugal Lipid Subfractions.- Post-Heparin Lipolytic Enzymes in Patients on CAPD.- Body Composition in Uremic Children on CAPD and Hemodialysis.- Protein and Amino Acid Losses from the Peritoneum during CAPD and CCPD.- Blood Pressure on CAPD: Relationship to Sodium Status, Renin, and Aldosterone, Compared with Hemodialysis.- Influence of Hypertension on Vision in Diabetics Undergoing Dialysis: Comparison of Peritoneal and Hemodialysis.- Bone Histomorphometry during Long-Term CAPD.- Effect of CAPD on Renal Osteodystrophy in Unmodified Patients Moving from Hemodialysis to CAPD.- The Trace Elements Br, Co, Cr, Cs, Cu, Fe, Mn, Rb, Se and Zn in Serum, Packed Cells, and Dialysate of CAPD Patients.- High Muscle Magnesium and Potassium in Long-Term Regular Dialysis Treatment.- Respiratory Function in CAPD.- Effect on Erythropoiesis of Normal Monocytes and Peritoneal Macrophages from CAPD Patients.- Creatine Kinase, Amylase, and Parathyroid Hormone in Stable CAPD and Hemodialysis Patients.- CK Isoenzymes in CAPD and Hemodialysis Patients.- Total CK and CK-MB Elevation in Dialysis Patients without Acute Myocardial Infarction.- Sexual Dysfunction in Patients Treated by CAPD.- Complications, Peritonitis, and Response to Infection.- Prognostic Indicators of Hernia Development in Patients Undergoing CAPD.- Peritoneal Catheter Perforating into the Colon—A Serious Complication of Peritoneal Dialysis.- CAPD, a Permanent State of Peritonitis: A Study on Peroxidase Activity.- A 3 1/2 Year Experience with Peritonitis in Children Undergoing CAPD and CCPD.- Incidence of Peritonitis and Delayed-Type Hypersensitivity in Patients on CAPD.- The Importance of Iron for Bacterial Growth in Peritoneal Dialysis Fluid.- The Importance of Intracellular Organisms in CAPD.- Immunologic Pattern in CAPD Patients with Low or High Peritonitis Incidence.- Defective Complement-Mediated Opsonization and Lysis of Bacteria in Commercial Peritoneal Dialysis Solutions.- Opsonizing Capacity of Peritoneal Fluid and Relationship to Peritonitis in CAPD Patients.- Opsonization Capacity of Plasma and Peritoneal Dialysate in CAPD Patients.- Opsonically-Active Proteins in CAPD Fluid.- Defective Peritoneal Polymorphonuclear Leukocyte Function in Patients on Intermittent Peritoneal Dialysis: Effects of Some Divalent Ions and Fibronectin.- Surface Marker Characterization of Peritoneal Dialysis Patients’ Intraperitoneal Leukocytes by Monoclonal Antibodies.- HLA Markers and Peritonitis in CAPD Patients.- Comparison of Lymphocyte Markers and Lymphoblastic Transformation Studies of Patients Converted from Hemodialysis to CAPD.- T Lymphocytes Subsets in CAPD and Hemodialysis (HD) Patients: A Prospective Study.- Immunoglobulins in CAPD.- Enhanced Peritoneal Generation of Vasoactive Prostaglandins during Peritonitis in Patients Undergoing CAPD.- Thromboxane and Prostaglandin Synthesis in Human Peritoneal Eosinophils.- A Comparison of the Stimulatory Effects of Prostaglandins on Human and Rat Peritoneal Macrophage cAMP Synthesis.- Alteration in Glucose Absorption During Peritonitis and Its Effects in Diabetic and Nondiabetic Patients Undergoing CAPD.- Suitability of Povidone-lodine Formulations for CAPD.- No Difference Between Oral and Intraperitoneal Treatment of CAPD Peritonitis with Cephradine.- Hazards of CAPD: Interleukin-1 Production.- Sclerosing Encapsulating Peritonitis and Other Complications of CAPD Peritonitis.- Sclerosing Peritonitis—A Further Complication of CAPD.- Sclerosing Encapsulating Peritonitis during CAPD. Evaluation of the Potential Risk Factors.